Axsome Therapeutics, Inc. (AXSM) vs Ionis Pharmaceuticals, Inc. (IONS)
- Axsome Therapeutics, Inc. AXSM 157.14 −2.87%
- Ionis Pharmaceuticals, Inc. IONS 42.94 −2.67%
Axsome Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. is the larger, with a market value of $8.5B against $7.3B — 1.2× the size. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against −7.41%. Axsome Therapeutics, Inc. has the higher net margin (−24.7% vs −64.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Axsome Therapeutics, Inc. leads on 9 and Ionis Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | AXSM | IONS | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.24% | 98.17% | 65.16% |
| Operating margin | (23.96%) | (68.00%) | 0.00% |
| Net margin | (24.68%) | (64.66%) | 0.00% |
| Free cash flow margin | (9.27%) | (64.93%) | 0.00% |
| Return on equity | (245.10%) | (105.50%) | (56.36%) |
| Return on assets | (27.35%) | (18.90%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack